https://www.selleckchem.com/products/Eloxatin.html
The mean delay time to detection of non-favorable risk cancer was between 0.38 and 2.17 years. Biopsy undersampling and progression varied considerably across study cohorts. There was no single best biopsy protocol that is optimal for all cohorts, because of the variation in biopsy under-sampling error and annual progression rates across cohorts. All strategies demonstrated diminishing benefits from additional biopsies. A systematic review and meta-analysis basing on the prospective cohort studies were conducted to explore the risk of
Like
Comment
Share
